Treatment of Relapses in ANCA-Associated Vasculitis
2019
Diagnostic and therapeutic advances for ANCA-associated vasculitis have improved 1-year survival, and ANCA-associated vasculitis is now considered a chronic relapsing disease. Avoiding long-term treatment toxicity and preventing, detecting, and treating relapses early are keys to improving quality
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
2
Citations
NaN
KQI